ZFIN ID: ZDB-PUB-141230-13
Differential regulation of Kit Ligand A (kitlga) expression in the zebrafish ovarian follicle cells - evidence for the existence of a cyclic adenosine 3', 5' monophosphate-mediated binary regulatory system during folliculogenesis
Yao, K., Ge, W.
Date: 2015
Source: Molecular and Cellular Endocrinology   402: 21-31 (Journal)
Registered Authors: Ge, Wei
Keywords: Epac, Kit ligand, Kitlga, PACAP, PKA, cAMP, hCG, ovary, zebrafish
MeSH Terms:
  • Animals
  • Cells, Cultured
  • Cyclic AMP/metabolism*
  • Cyclic AMP-Dependent Protein Kinases/metabolism
  • Female
  • Gene Expression
  • Gene Expression Regulation, Developmental
  • Guanine Nucleotide Exchange Factors/metabolism
  • Luteinizing Hormone/physiology
  • Oogenesis*
  • Ovarian Follicle/growth & development
  • Ovarian Follicle/metabolism*
  • Proto-Oncogene Proteins c-akt/metabolism
  • Second Messenger Systems
  • Stem Cell Factor/genetics*
  • Stem Cell Factor/metabolism
  • Zebrafish
  • Zebrafish Proteins/genetics*
  • Zebrafish Proteins/metabolism
PubMed: 25542847 Full text @ Mol. Cell. Endocrinol.
FIGURES
ABSTRACT
Kit ligand (Kitl) is an important paracrine factor involved in the activation of primordial follicles from the quiescent pool and in the maintenance of meiotic arrest before germinal vesicle breakdown (GVBD). It has been reported that follicle-stimulating hormone (FSH) stimulates but luteinizing hormone (LH) suppresses the expression of Kitl in the granulosa cells in mammals. Considering that both gonadotropins signal in the follicle cells mainly by activating cyclic adenosine 3', 5'-monophosphate (cAMP) pathway, we are intrigued by how cAMP differentially regulates Kitl expression. In the present study, we demonstrated that both human chorionic gonadotropin (hCG) and pituitary adenylate cyclase activating polypeptide (PACAP) inhibited insulin-like growth factor I (IGF-I)-induced Akt phosphorylation and kitlga expression in the zebrafish follicle cells. Further experiments showed that cAMP was involved in regulating the expression of kitlga. However, two cAMP-activated effectors, protein kinase A (PKA) and exchange protein directly activated by cAMP (Epac), had converse effects. PKA promoted whereas Epac inhibited the expression of kitlga, as demonstrated by the respective activators. Interestingly, cAMP also appeared to exert differential effects on kitlga expression at different stages of follicle development during folliculogenesis, significantly stimulating kitlga expression at the early growth stage but suppressing it at the full-grown stage before final oocyte maturation, implying a potential mechanism for differential effects of the same pathway at different stages. The inhibitory effect of forskolin (activator of adenylate cyclase) and H89 (inhibitor of PKA) on IGF-I-induced expression of kitlga suggested cross-talk between the cAMP and IGF-I-activated PI3K-Akt pathways. This study, together with our previous findings on IGF-I regulation of kitlga expression, provides important clues to the underlying mechanism that regulates Kit ligand expression during folliculogenesis in the ovary.
ADDITIONAL INFORMATION